PATENT CLAIM ANALYSIS

Application Number: 15875692
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "338000"]

Abstract:
A pharmaceutical composition containing isomyosmine or a pharmaceutically acceptable salt thereof is administered to an individual in need thereof for treating a substance addiction, inclusive of addiction to heroin (diacetylmorphine), cocaine, opioids, methadone, d-methamphetamine, barbiturates, alcohol, benzodiazepines, amphetamines, or buprenorphine. The isomyosmine, along with optional additional therapeutic agent(s), may be administered in a capsule, tablet, or lozenge.

Claim (Index 12):
The method of  claim 1 , wherein the pharmaceutical composition is administered via a capsule, tablet, or lozenge.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15522815', '12826985', '10396319', '14624376', '13537536']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7733038204158481
- 35 USC 102 Novelty (BERT): 0.5084971350196419
- Combined Prediction Score: 0.7468231518762275
- Mean Citation Score: 226.935352
- Max Citation Score: 263.16202000000004
- Similarity Product: 195.5963039964891

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test